These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34479915)

  • 1. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile.
    Seth A; Amemiya Y; Cheung H; Hsieh E; Law C; Milot L
    Cancer Genomics Proteomics; 2021; 18(5):627-635. PubMed ID: 34479915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L
    Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L
    Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Cheung HMC; Karanicolas PJ; Coburn N; Seth V; Law C; Milot L
    Eur Radiol; 2019 Feb; 29(2):1032-1038. PubMed ID: 29992388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor enhancement of colorectal liver metastases on preoperative gadobutrol-enhanced MRI at 5 minutes post-contrast injection is associated with overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Quant Imaging Med Surg; 2019 Feb; 9(2):312-317. PubMed ID: 30976555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
    Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
    Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
    Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
    Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of liver-specific contrast-enhanced MRI before resection of colorectal liver metastases].
    Dede K; Kátai T; Demjén B; Nagy Z; Egyed T; Varga M; Egyed Z; Bursics A
    Orv Hetil; 2021 Dec; 162(50):2010-2016. PubMed ID: 34896985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
    Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
    HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
    Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
    PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
    Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
    Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
    Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
    Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Yamashita S; Chun YS; Kopetz SE; Maru D; Conrad C; Aloia TA; Vauthey JN
    Ann Surg; 2020 Dec; 272(6):1080-1085. PubMed ID: 28379870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents.
    Seo N; Park MS; Han K; Lee KH; Park SH; Choi GH; Choi JY; Chung YE; Kim MJ
    Cancer Res Treat; 2018 Jan; 50(1):60-70. PubMed ID: 28292007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
    Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
    BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy.
    Tampellini M; Gned D; Baratelli C; Brizzi MP; Ottone A; Alabiso I; Bertaggia C; Di Maio M; Scagliotti GV; Veltri A
    Radiol Med; 2016 Dec; 121(12):950-957. PubMed ID: 27601143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases.
    Reynolds IS; Cromwell PM; Ryan ÉJ; McGrath E; Kennelly R; Ryan R; Swan N; Sheahan K; Winter DC; Hoti E
    Front Oncol; 2022; 12():821159. PubMed ID: 35265523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.